© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#blood cancer

Yescarta, CAR-T, axicabtagene ciloleucel
CAR-T Therapy: Lifeline to A Cure?
Imbruvica Bests Chemotherapy for Older People With Leukemia
Blood Cancers 101
Norm McDonald

Norm MacDonald’s Death Puts Spotlight on Acute Leukemia

Colorado University Cancer Center member Dan Pollyea, MD, says the disease can still be deadly despite advances in treatment.
Charlie Callagan at home in Merlin, Oregon

COVID-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment

Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
John Byrd, MD

Treating Blood Cancers

Hematologist John Byrd, MD, is chair of the Department of Internal Medicine at the University of Cincinnati College of Medicine.

COVID-19 Vaccine Response

COVID-19 vaccines are safe for people with cancer.

Many Cancer Patients Should Receive Third COVID-19 Vaccine Dose

Certain types of cancer treatment can lead to inadequate immune response.

U.S. OK’s Third COVID-19 Vaccine Dose for Immunocompromised People

The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.

New Concerns About Coronavirus Evolution in Immunosuppressed Patients

Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.

If You Are Immunocompromised, Should You Be Able To Get A COVID-19 Vaccine Booster Shot?

Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

25% of Blood Cancer Patients May Not Respond to COVID-19 Vaccines

A study from the Leukemia & Lymphoma Society finds that antibody production varies widely across blood cancer types.

Some Young Adult Cancer Survivors Are Hesitant About COVID-19 Vaccines

These findings, however, may reflect regional attitudes in Utah and the surrounding area.

FDA Ayvakit for Advanced Systemic Mastocytosis

Sonia Dolinger

Youngish With Cancer

Sonia Dolinger runs a meal delivery business and fundraises for cancer research. She has chronic lymphocytic leukemia.

FDA Approves New Sarclisa Regimen for Multiple Myeloma

The monoclonal antibody reduces the risk of disease progression or death by 45%.
Chimeric antigen receptor T-cell (CAR-T) therapy

FDA Approves New CAR-T Therapy for Multiple Myeloma

More than 70% of people treated with Abecma, a customized immunotherapy, experienced complete or partial remission.

Cancer Patients and Transplant Recipients Need Both COVID-19 Vaccine Doses

Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Advertisement
Science News
Features